Raaj Medisafe India Ltd (RAAJMEDI) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Raaj Medisafe India Ltd on NSE and BSE, with an AI summary of each filing.
We herewith submit the consolidated Scrutinizer Report dated 21.09.2026 of remote evoting and venue evoting in respect of the business transacted at the 41st. AGM held on Monday, the 21st ....
Annual General Meeting · 22 Sept 2026, 11:35 pm
We submit herewith proceedings of AGM of the shareholders of the Company held on Monday, the 21st day of September, 2026 at 3.00 PM.
Annual General Meeting · 22 Sept 2026, 8:33 pm
The Outcome of the AGM held on 21st September, 2026 held at 03.00 P.M. and concluded at 03.41 P.M. (including 15 minutes for E- voting after the conclusion of the meeting) as per letter ....
Annual General Meeting · 21 Sept 2026, 9:45 pm
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Krishna Jajoo & PACs
Acquisition/ Disposal of Shares · 16 Sept 2026, 11:37 pm
Raaj Medisafe India Discloses Inter-Se Promoter Equity Transfer via Gift Promoter Krishna Jajoo transferred 26,993 equity shares, representing a 0.16% stake in Raaj Medisafe India Limited, to Vishnu Jajoo HUF via an off-market inter-se gift on 15th Sep'26. Following this disposal, Krishna Jajoo's direct holding decreased from 0.16% to Nil. Because the transaction constitutes an inter-se transfer within the promoter group, the aggregate promoter and promoter group shareholding remains unchanged across the company's total equity capital base of Rs. 16,42,43,120 comprising 1,64,24,312 shares.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Brahma Swaroop Jajoo & PACs
Acquisition/ Disposal of Shares · 16 Sept 2026, 11:36 pm
Raaj Medisafe India Discloses Promoter Inter-Se Share Transfer via Gift Promoter Brahma Swaroop Jajoo transferred 1,94,700 equity shares (representing a 1.19% stake) of Raaj Medisafe India Limited to Vishnu Jajoo HUF on 15th Sep'26. The off-market inter-se transfer was executed by way of a gift between immediate relatives within the promoter group. Following the disposal, Brahma Swaroop Jajoo's direct holding decreased from 1.19% to Nil, while aggregate promoter and promoter group shareholding remained unchanged. The company's total equity base stands at 1,64,24,312 shares valued at Rs. 16.42 crore.
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vishnu Jajoo HUF & PACs
Acquisition/ Disposal of Shares · 16 Sept 2026, 10:24 pm
Raaj Medisafe Promoter Group Executes Inter-Se Transfer of 1.35% Equity Stake Vishnu Jajoo HUF acquired 2,21,693 equity shares, representing a 1.35% stake in Raaj Medisafe India Limited, via an off-market inter-se transfer by way of gift on 15th Sep'26. The shares were transferred by promoter group members Brahma Swaroop Jajoo (1,94,700 shares or 1.19%) and Krishna Jajoo (26,993 shares or 0.16%). Following the transaction, Vishnu Jajoo HUF holds a 1.35% stake, while the aggregate holding of the promoter and promoter group remains unchanged.
We are glad to inform you that the Company has received a Letter of award from Madhya Pradesh public health services corporation limited for supply of Baby Diappers to various governement ....
Others (Uncategorized) · 31 Aug 2026, 9:12 pm
Raaj Medisafe Secures ₹17.02 Crore Order from Madhya Pradesh Govt Raaj Medisafe India has secured a Letter of Award (LOA) from Madhya Pradesh Public Health Services Corporation for ₹17.02 crores, inclusive of GST. The contract, announced on 31 Aug'26, involves the supply of 29.88 million baby diapers to various government hospitals in the state. The order is to be executed within 18 months from the contract date. This domestic order carries no promoter group interest and is not a related-party transaction, representing a direct revenue-generating event for the company.
We hereby submit the Notice of 41st Annual General meeting of the members of the Company Scheduled to be held on Monday, the 21st day of September, 2026
Annual General Meeting · 27 Aug 2026, 9:45 pm
We submit herewith letters sent to Shareholders under Regulation 36(1)(b) of SEBI (LODR), Regulations, 2015, whose e-mail IDs are not registered with Company/RTA/Depositories
Others (Uncategorized) · 26 Aug 2026, 11:46 pm
Raaj Medisafe Sets 41st AGM for 21st Sep'26 Raaj Medisafe India has scheduled its 41st Annual General Meeting (AGM) for 21st Sep'26 at 3:00 PM via video conference. The company has dispatched its FY26 Annual Report to shareholders. Key dates include a cut-off date for e-voting on 14th Sep'26. The e-voting window will be open from 18th Sep'26 (9:00 AM) to 20th Sep'26 (5:00 PM). Shareholders are requested to update their email addresses and complete KYC formalities to ensure participation and receipt of communications.
Pursuant to Regulation 34 (1) of SEBI (LODR) Regulations, 2015, we submit herewith Annual Report 2026 of the Company.
Others (Uncategorized) · 26 Aug 2026, 11:39 pm
We submit herewith Unaudited Financial Results for the Quarter ended June 30, 2026 together with Limited Review Report.
Financial Result · 12 Aug 2026, 11:07 pm
Raaj Medisafe Q1FY27: Strong Revenue Growth and Profitability Raaj Medisafe reported strong Q1FY27 results, with revenue from operations growing 86.1% YoY to ₹2,945.91 lakhs. Net profit for the quarter ended Jun 30, '26, increased by 35.1% YoY to ₹197.37 lakhs from ₹146.06 lakhs a year prior. Quarter-over-quarter, revenue rose 17.5% from ₹2,507.68 lakhs. Basic EPS stood at ₹1.20, up from ₹1.11 YoY. The Plastics Division was the primary revenue driver, contributing ₹2,112.00 lakhs. The board approved these unaudited results on Aug 12, '26.
We submit herewith statement of Variation/deviation of utilization of Funds raised by way of Preferential Allotment on 26.03.2026
Others (Uncategorized) · 12 Aug 2026, 10:12 pm
Raaj Medisafe Reports No Deviation in Use of Preferential Issue Funds Raaj Medisafe India reported no deviation or variation in the utilization of funds for the quarter ended 30 Jun'26. The company had raised Rs. 18.01 crore through a preferential issue on 26 Mar'26. The stated objectives included acquiring plant, machinery, and business operations of Fabrizo Industries' Goa unit, funding expansion plans, enhancing manufacturing capacity, and for working capital. The Audit Committee reviewed the utilization statement on 12 Aug'26 and noted no discrepancies, confirming funds are being used as originally disclosed.
The Board of Directors of the Company in its meeting held on 12.08.2026 has appointed Mr. Vipul Parakh as Chief Financial officer of the Company.
Change in Management · 12 Aug 2026, 10:04 pm
Raaj Medisafe Appoints New Chief Financial Officer Raaj Medisafe India appointed Mr. Vipul Parakh as its new Chief Financial Officer, effective 12 Aug '26. Mr. Parakh is a Chartered Accountant with over 28 years of experience in both the service and manufacturing sectors. His expertise includes financial reporting, budgeting, compliance, SAP implementation, and strategic financial planning. The appointment was made by the Board of Directors in their meeting on the same date.
The Board of Directors in its meeting held on August 121, 2026 has inter-alia approved and taken on record Unaudited Financial Results for the quarter ended June 30, 2026. Details of other ....
Outcome · 12 Aug 2026, 9:54 pm
Raaj Medisafe: Board Meeting Highlights and Key Dates Announced Raaj Medisafe's board approved unaudited financials for the quarter ending 30th Jun'26. The company appointed Mr. Vipul Parakh as CFO effective 12th Aug'26, following the resignation of Ms. Fatema Dadani Patel. The 41st AGM is scheduled for 21st Sep'26 via video conference. The record date for e-voting eligibility is set for 14th Sep'26. The Register of Members will be closed from 15th Sep'26 to 21st Sep'26 (inclusive). Other reports, including corporate governance and shareholding patterns, were also noted.
Raaj Medisafe India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve A meeting of the Board ....
Intimation · 12 Aug 2026, 5:30 am
Raaj Medisafe Board Meeting on Aug 12, 2026 to Review Q1 Results, Appoint CFO Raaj Medisafe India's board will meet on 12 Aug'26 to consider and approve the unaudited financial results for the quarter ended 30 Jun'26. Key agenda items also include the appointment of a Chief Financial Officer (CFO) and the approval of the Directors' and Corporate Governance reports for the year ended 31 Mar'26. The board will also decide on the date and details for the 41st Annual General Meeting and review various compliance reports.
We forward herewith resignation letter dated July 10, 2026 received From Kanije Fatema Dadani Patel resigning from the post of Chief Financial Officer of the Company wef July 14, 2026
Change in Management · 10 Jul 2026, 11:03 pm
Raaj Medisafe India's CFO Kanije Fatema Dadani Patel to Step Down Raaj Medisafe India announced that CFO & KMP Kanije Fatema Dadani Patel has resigned to pursue new professional opportunities and for personal reasons. Her resignation was tendered on 10th Jul'26 and will be effective from the close of business on 14th Jul'26. The company has accepted her resignation and noted she will assist in a smooth transition, potentially providing support beyond her effective date. This constitutes a change in Key Managerial Personnel under SEBI regulations.
We attach herewith Statement of Deviation/Variation under Regulation 32 (1) of SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 30 May 2026, 12:59 am
Raaj Medisafe Reports No Deviation in Use of Preferential Issue Funds Raaj Medisafe India Ltd. confirmed no deviation or variation in the utilization of funds for the quarter ended 31 Mar'26. The company had raised Rs. 18.01 crore through a preferential issue on 26 Mar'26. The filing, reviewed by the Audit Committee on 29 May'26, stated that the funds were used in line with the objects stated in the offering documents, with no modifications. The report received no adverse comments from the auditors or the Audit Committee, indicating adherence to the stated capital deployment plan.
We attach herewith the following: a. Declaration of unmodified opinion b. Audited Financial Results for he quarter/year ended March 31, 2026, Declaration of unmodified opinion, Auditors ....
Financial Result · 30 May 2026, 12:49 am
Raaj Medisafe FY26 Results: Net Loss Recorded in Q4 Despite Annual Revenue Growth Raaj Medisafe reported a net loss of ₹322.63 lakhs for Q4 FY26, a sharp decline from the ₹348.01 lakh profit in Q4 FY25. This was driven by a significant increase in total tax expenses to ₹451.25 lakhs. For the full year FY26, net profit fell 70.5% YoY to ₹180.97 lakhs, while revenue from operations grew 28.2% YoY to ₹8,001.46 lakhs. The company's board noted a strategic expansion of production capacity, expected to be completed during FY27. Basic EPS for FY26 stood at ₹1.10.
The Board of Directors of the Company in its meeting held on May 29, 2026 has inter-alia approved the following: a. Audited Financial Statements and cash Flow Statements for the year ....
Outcome · 29 May 2026, 11:07 pm
Raaj Medisafe Board Approves Audited Financials for Q4 & FY26 The Board of Directors, in a meeting on 29-May'26, approved and took on record the Audited Financial Results, Financial Statements, and Cash Flow Statement for the quarter and year ended 31-Mar'26. The board also noted the Draft Auditors Report for the same period. Additionally, approvals were granted for related party transactions for H2 FY26, the Integrated (Finance) Report, and the adoption of the Reconciliation of Share Capital Audit for Q4 FY26. The company's shareholding pattern for the quarter was also taken on record.
Raaj Medisafe India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Please be informed that ....
Intimation · 29 May 2026, 5:30 am
Raaj Medisafe Board Meeting on May 29 to Approve Q4 and FY26 Results Raaj Medisafe India (BSE: 524502) has scheduled a Board of Directors meeting on 29 May'26. The key agenda is to consider and approve the audited financial results, including the statement of assets and liabilities and cash flow statement, for the quarter and financial year ended 31 Mar'26. The board will also review related party transactions, fund utilization from preferential allotment, and the shareholding pattern for the quarter. The meeting will be held at 3:00 PM at the company's registered office.
The Board of Directors of Raaj Medisafe India Limited ('the Company') at its meeting held today, i.e., 26th March, 2026, approved the allotment of 32,75,000 fully paid-up equity shares ....
Outcome · 26 Mar 2026, 10:01 pm
Raaj Medisafe Board Approves Allotment of Shares via Preferential Issue Raaj Medisafe India's board, on 26 Mar'26, approved the allotment of 32,75,000 equity shares through a preferential issue for cash consideration. The shares, with a face value of Rs. 10, were priced at Rs. 55.00 each, including a premium of Rs. 45. This capital raise totals approximately Rs. 18.01 crore. The shares were allotted to non-promoter entities. Following the allotment, an application for listing approval will be submitted to the stock exchange in due course.
Raaj Medisafe India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/03/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Intimation · 20 Mar 2026, 8:00 pm
Raaj Medisafe Board to Consider Preferential Allotment of 32.75 Lakh Shares Raaj Medisafe India Ltd. has scheduled a Board of Directors meeting for 26 Mar'26 at 3:45 PM. The primary agenda item is to consider and approve the issuance and allotment of 32,75,000 equity shares on a preferential basis. The meeting will also review minutes from previous board and committee meetings. This corporate action is subject to board approval.
Attached corrigendum to Unadudited Financail Results for the quarter ended December 2025
Others (Uncategorized) · 12 Feb 2026, 6:55 pm
Raaj Medisafe Reports Strong Q3FY26 Results with 85% YoY Net Profit Growth Raaj Medisafe India reported strong Q3FY26 results, with net profit surging 84.8% YoY to ₹189.42 lakhs from ₹102.52 lakhs. Revenue from operations for the quarter ended 31st Dec'25 grew 42.0% YoY to ₹2,070.68 lakhs. On a QoQ basis, revenue increased 12.5% while net profit rose 9.7%. The performance was driven by the Plastic segment, which contributed 68.5% of the total segment revenue. A corrigendum was issued to correct a typographical error, confirming the Board meeting date as 11th Feb'26.
We are enclosing herewith unaudited financial results along with limited review for the quarter ended on December 31, 2025
Financial Result · 11 Feb 2026, 10:49 pm
Raaj Medisafe Q3FY26: Strong YoY Growth in Revenue and Profitability Raaj Medisafe India reported a robust Q3FY26 performance, with revenue from operations growing 41.9% YoY to ₹2,070.68 lakhs. Net profit surged 84.8% YoY to ₹189.42 lakhs from ₹102.52 lakhs in Q3FY25. On a QoQ basis, revenue increased 12.5% while net profit grew 9.7%. Higher material and finance costs partially moderated margins. Basic EPS for the quarter stood at ₹1.44, up from ₹0.76 in the prior year's quarter. The company's board approved the unaudited results on 11 Feb'26.
The Board of Directors of the Company in its meeting held on February 11, 2026 has, inter-alia approved/taken on record as per Board Meeting Notice dated Feb. 02,2026 We are enclosing ....
Outcome · 11 Feb 2026, 10:30 pm
RAAJ MEDISAFE INDIA LIMITED - Financial Result for the Quarter ended 31st Dec'25 (Standalone, INR Lakh) ■ Revenue: 780 (+3.6% YoY | -20.4% QoQ) ■ EBITDA: 97.0 (-33.1% YoY | -52.9% QoQ) ■ EBITDA Margin (%): 12.4 (-682 bps YoY | -861 bps QoQ) ■ PAT: 37.1 (-46.5% YoY | -66.7% QoQ) ■ EPS (INR): 0.37 (-46.4% YoY | -66.7% QoQ)